EULAR 2025 highlights… EULAR 2025 Highlights – Other Connective Tissue Diseases and Vasculitis 18 Jul 202522 Jul 2025 EFFICACY AND SAFETY OF EFGARTIGIMOD PH20 SC IN ADULT PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY: PHASE 2 RESULTS FROM THE ALKIVIA STUDY Abstract format and assignment number: Oral presentation OP0002 Date: Wednesday,…
EULAR 2025 highlights… EULAR 2025 Highlights- Rheumatoid Arthritis: Clinical (therapeutic) 18 Jul 2025 Cancer Risk in Patients with Rheumatoid Arthritis Receiving Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Data from a Multicenter National Real-World Registry Abstract format and assignment number: Oral presentation…
EULAR 2025 highlights… EULAR 2025 Highlights – Spondyloarthritis: Clinical (therapeutic) 18 Jul 2025 Superior effectiveness and comparable drug retention of anti-TNF therapy versus anti-IL-17A in ankylosing spondylitis after first anti-TNF failure: A propensity score-matched analysis from the Czech ATTRA Registry Abstract format and…
EULAR 2025 highlights… EULAR 2025 Highlights – Spondyloarthritis: Clinical (non-therapeutic) 18 Jul 2025 Impact of Residual Disease on Disease Flares in Axial Spondyloarthritis: A Longitudinal Study in a Dutch Clinical Practice Registry Abstract format and assignment number: Oral presentation OP0097 Date: Wednesday, 11…
EULAR 2025 highlights… EULAR 2025 Highlights – Rare and Autoinflammatory diseases 18 Jul 202518 Jul 2025 A WINDOW OF OPPORTUNITY IN STILL’S DISEASE: THE EARLY INTRODUCTION OF IL-1 INHIBITORS FOR ACHIEVING CLINICAL INACTIVE DISEASE Abstract format and assignment number: Poster 0377 Presenting author: S. Bindoli (Italy)…
EULAR 2025 highlights… EULAR 2025 Highlights – Metabolic and Crystal arthropathies 18 Jul 2025 Genakumab reduces the risk of acute gout flares during initiation of urate-lowering therapy: A phase 2, randomized, open-label, multi-center, active-controlled clinical trial Abstract format and assignment number: Oral presentation OP0299…
SLE & APS EULAR 2025: Do Not Miss –SLE & APS 1 Jun 20259 Jun 2025 Claudia IannoneCountry: Italy Claudia is a Rheumatology resident at Milan University, carrying out her research at Gaetano-Pini Hospital in Milan, Italy. Her research interests are focused systemic sclerosis, interstital lung…
Connective Tissue Diseases and Vasculitis EULAR 2025: Do Not Miss – Vasculitis and other connective tissue diseases 1 Jun 20259 Jun 2025 Gozde Kubra YardimciGozde had a rheumatology training at the Hacettepe University Faculty of Medicine, Ankara, Turkey. She completed her Vasculitis Clinical Research Consortium (VCRC)- Vasculitis Foundation (VF) Fellowship at the Mount…
Rheumatoid Arthritis I – Clinical (non-therapeutic) EULAR 2025: Do Not Miss – Rheumatoid Arthritis I – Clinical (non-therapeutic) 1 Jun 20258 Jun 2025 Ufuk IlgenUfuk is a rheumatologist. Currently, he is doing his MSc in Translational Medical Research Programme at Heidelberg University, Germany. His main clinical and research interests are the immunopathological background…
Rheumatoid arthritis II - therapeutic EULAR 2025: Do Not Miss – Rheumatoid arthritis II – Clinical (therapeutic) 1 Jun 20251 Jun 2025 Stephanie LingSteph is an NIHR Academic Clinical Lecturer, carrying out her research at the University of Manchester. Her research interests are focused on analysis of multi-omics methods to define predictors…